Read the Beforeitsnews.com story here. Advertise at Before It's News here.

By Shadow Stock (Reporter)
Contributor profile | More stories

Story Views
Now:
Last hour:
Last 24 hours:
Total:

PetMeds (PETS): The Hidden Cost Cutting Opportunities That Could Drive a Return to Profitability

Saturday, June 13, 2026 16:03

% of readers think this story is Fact. Add your two cents.

PetMed’s market price has been hit hard by declining revenue. Revenue fell from $227 million in FY2025 to $179 million in FY2026. The stock trades as if survival is in question.

Now the question is how PetMeds can become profitable again. During the recent earnings call, management announced that they saved about $6.1 million a year. That is not enough. Material additional savings exist if management aggressively right-sizes the business.

Management has already taken steps to improve efficiency and reduce costs. The company has reorganized its pharmacy, call center, and distribution operations. Headcount was reduced, and existing underperforming vendor relationships ended. Furthermore, they implemented a new ERP system, a new call center platform, and a fraud-prevention system. Together, it’s expected to generate approximately $6.1 million in annualized cost savings.

Let’s examine the remaining opportunities for meaningful cost savings.

Consolidate to One Distribution Center

This may be the largest hidden opportunity. PetMeds currently operates two pharmacy and distribution facilities. One in Delray Beach, Florida, and Lynbrook, New York, versus annual revenues of $179 million. It might not be economical to have two warehouses, pharmacies, and duplicate inventory. Consolidating operations will lower facility expenses, utilities, rent, and property costs. Savings would also include warehouse payroll and inventory carrying costs. Estimated annual savings could be $2 million to $4 million. The main risk is that the New York pharmacy license may have strategic value. This consolidation could negatively impact delivery times for Northeast customers. The estimated savings are not supported by any direct evidence from management.

Call Center Automation

PetMeds mentions investments in AI, automation, call center technology, and digital customer service. Customer service remains a significant operating expense. Routine order inquiries, such as prescription refills, shipping, and autoship, can be automated. A 10% to 20% reduction in customer service staffing could generate annual savings of 1 to 2 million. The savings are primarily due to reduced headcount is reasonable but not proven.

Corporate Overhead

PetMeds currently employs approximately 189 people while generating $179 million in annual revenue. The company has also experienced significant executive turnover. Currently operating with an interim CEO and interim CFO. PetMeds still has opportunities to streamline its corporate structure. Human resources, finance, legal, compliance, and marketing could all gain efficiency. Estimated annual savings are $1 million to $3 million. The saving thesis is reasonable, but not directly supported by company disclosures.

Marketing Efficiency

Management has stated that it is shifting marketing spending. Advertising expenses totaled approximately $5.8 million in the fourth quarter. And roughly $23 million annually. Even a modest 10% reduction in advertising costs could save more than $2 million a year.

Eliminate Low Margin Categories

Management disclosed a failed wholesale initiative. The $2.1 million inventory write-off indicates expanding into low margin items. Potential candidates include low-margin foods, bulky products, and slow-moving inventory. A focused SKU program could reduce inventory levels and lower working capital requirements. EBIT improvement is possible in the estimated range of $0.5 million to $2 million. This is hard to prove quantitatively because the evidence for the savings is indirect.

Procurement and Supplier Rebates

According to the 10-K, 88% of PetMeds’ inventory purchases come from ten suppliers. This level of supplier concentration provides meaningful negotiating leverage. Potential opportunities include securing better supplier rebates, improved payment terms, and volume discounts. Even modest improvements in procurement costs could have a significant impact on profitability. The estimated annual savings are $1 million to $3 million; the estimate is speculative.

Public Company Costs

PetMeds is a NASDAQ-listed company with a market capitalization of $35 million. Expenses include audits, SEC compliance, legal fees, board compensation, and investor relations. Management has also highlighted elevated professional fees during the past year. If PetMeds were acquired by an outside party. Many of these costs could be eliminated immediately. Estimated annual savings are $2 million to $4 million. It’s for the reasons a strategic buyer might pay a premium.

The opportunity for additional cost savings appears significant. Distribution consolidation could generate $2 million to $4 million annually. Call center automation may contribute another $1 million to $2 million. Streamlining corporate overhead could save $1 million to $3 million. And marketing optimization may provide an additional $1 million to $2 million. SKU rationalization could improve EBIT by $0.5-$2 million. Supplier negotiations may add another $1 million to $3 million. In total, these initiatives could yield an annual profit improvement of approximately $6.5 million to $16 million.

Can PETS Reach a Positive EBITDA?

Based on FY2026 results, PetMeds reported revenue of $179 million and a net loss of $57.3 million. Adjusted EBITDA in the fourth quarter was approximately negative $2.8 million. Annualizing suggests the business is currently operating at roughly negative $10 million to negative $12 million of EBITDA.

So, additional cost reductions of $6 million to $10 million could potentially move the company into a positive EBITDA of $2 million to $8 million.

If revenue stays around current levels and management executes the announced and additional cost-saving measures. PetMeds could generate positive EBITDA of $5 million to $12 million without returning to the $227 million revenue level it reached a year ago.

Conclusion

The $6.1 million savings number has hard evidence from management. THE OTHER SAVINGS ESTIMATES ARE ASSUMPTIONS, NOT COMPANY GUIDANCE!

Long PETS

Source: http://shadowstock.blogspot.com/2026/06/petmeds-pets-hidden-cost-cutting.html

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

LION'S MANE PRODUCT

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.

Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

Comments

Visits:	1,813,444,311
Stories:	8,657,206